TikTok Content Creators Fueling Parallel Market for Unlicensed Weight-Loss Drug
A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and pharmacists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Some experts stated the popularity for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, legal action or prison.
Service Reaction and Material Elimination
Based on the social media company, the service has taken down problematic material and banned associated hashtags and query recommendations. The organization said it was dedicated to keeping the platform secure and investing in enhancing compliance measures.
Online Trading Operations
Research also discovered communities with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, filled with photos of weight loss, glowing reviews and detailed guides for mixing or injecting at residence.
After moments of joining one community, a vendor posted contact information, where most transactions occur. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, medical conditions or previous experience.
Product Information and Costs
Within these groups, posts display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for Telegram said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has already seen patients harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose users to potentially significant medical dangers”.